Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa
Vadim Lincoln,Jon Cogan,Yingping Hou,Michaela Hirsch,Michelle Hao,Vitali Alexeev,Michele De Luca,Laura De Rosa,Johann W. Bauer,David T. Woodley,Mei Chen
DOI: https://doi.org/10.1073/pnas.1803154115
IF: 11.1
2018-06-26
Proceedings of the National Academy of Sciences
Abstract:Significance Premature termination codons (PTCs) generated by nonsense mutations produce abnormal, short, or diminished proteins. Eighty-three percent of patients with Herlitz junctional epidermolysis bullosa (H-JEB), an inherited, incurable skin disease, harbor nonsense mutation(s) in genes encoding a structural protein (laminin 332) responsible for skin adherence. Gentamicin, a common antibiotic, was shown to induce readthrough of PTCs in various disease models. Using in vitro assays and 3D skin models, we found that H-JEB cells harboring nonsense mutations exposed to gentamicin produce full-length structural protein, deposit it correctly between skin layers, and exhibit reversal of other H-JEB–associated cellular abnormalities. Our findings indicate that gentamicin may present an immediate therapy for this otherwise fatal disease and other skin disorders caused by nonsense mutations.
multidisciplinary sciences